Neurodevelopmental and neurobehavioral characteristics in males and females with CDKL5 duplications

European Journal of Human Genetics

Volumn 23, Issue 7, 2015, Pages 915-921

  Szafranski, Przemyslaw ^a   Golla, Sailaja ^b   Jin, Weihong ^a   Fang, Ping ^a   Hixson, Patricia ^a   Matalon, Reuben ^c   Kinney, Daniel ^d   Bock, Hans Georg ^e   Craigen, William ^a   Smith, Janice L ^a   Bi, Weimin ^a   Patel, Ankita ^a   Wai Cheung, Sau ^a   Bacino, Carlos A ^a   Stankiewicz, Paweł ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d Memorial Hospital of South Bend   (United States)

^e UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE LIKE 5; GENOMIC DNA; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; CDKL5 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; AUTISM; CHILD; CLINICAL ARTICLE; COGNITION; DEVELOPMENTAL DISORDER; DNA SEQUENCE; DNA TEMPLATE; ETHNICITY; FEMALE; GENE DUPLICATION; GENOTYPE; HETEROZYGOTE; HUMAN; INTELLECTUAL IMPAIRMENT; LEARNING DISORDER; MACROCEPHALY; MALE; MATHEMATICS; MICROARRAY ANALYSIS; MOTHER; NERVE CELL DIFFERENTIATION; OBSESSIVE COMPULSIVE DISORDER; PHENOTYPE; POINT MUTATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SPEECH DELAY; SPEECH DISORDER; STEREOTYPY; X CHROMOSOME INACTIVATION; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISABILITIES; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC PREDISPOSITION; GENETICS; INHERITANCE; LANGUAGE DEVELOPMENT DISORDERS; MEGALENCEPHALY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AUTISTIC DISORDER; BASE SEQUENCE; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; DEVELOPMENTAL DISABILITIES; FEMALE; GENE DUPLICATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INHERITANCE PATTERNS; LANGUAGE DEVELOPMENT DISORDERS; MALE; MEGALENCEPHALY; MOLECULAR SEQUENCE DATA; PROTEIN-SERINE-THREONINE KINASES; SEQUENCE ANALYSIS, DNA; X CHROMOSOME INACTIVATION;

EID: 84930870955     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2014.217     Document Type: Article

References (53)

1. Amir RE, Van den Veyver IB, Wan M et al: Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23: 185-188.
2. Miltenberger-Miltenyi G, Laccone F: Mutations and polymorphisms in the human methyl CpG-binding protein MECP2. Hum Mutat 2003; 22: 107-115.
3. Neul JL, Kaufmann WE, Glaze DG et al: Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010; 68: 944-950.
4. Weaving LS, Christodoulou J, Williamson SL et al: Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet 2004; 75: 1079-10935.
5. Tao J, Van Esch H, Hagedorn-Greiwe M et al: Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelop-mental retardation. Am J Hum Genet 2004; 75: 1149-1154.
6. Bienvenu T, Chelly J: Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized. Nature Rev Genet 2006; 7: 415-426, Note: Erratum: Nat Rev Genet 2006; 7: 583.
7. Russo S, Marchi M, Cogliati F et al: Novel mutations in the CDKL5 gene, predicted effects and associatedphenotypes. Neurogenetics 2009; 10: 241-250.
8. Rademacher N, Hambrock M, Fischer U et al: Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and Rett-like features. Neurogenetics 2011; 12: 165-167.
9. Ariani F, Hayek G, Rondinella D et al: FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 2008; 83: 89-93.
10. Mencarelli MA, Spanhol-Rosseto A, Artuso R et al: Novel FOXG1 mutations associated with the congenital variant of Rett syndrome. J Med Genet 2010; 47: 49-53.
11. Philippe C, Amsallem D, Francannet C et al: Phenotypic variability in Rett syndrome associated with FOXG1 mutations in females. J Med Genet 2010; 47: 59-65.
12. Rusconi L, Salvatoni L, Giudici L et al: CDKL5 expression is modulated during neuronal development and its subcellular distribution is tightly regulated by the C-terminal tail. J Biol Chem 2008; 283: 30101-30111.
13. Kilstrup-Nielsen C, Rusconi L, La Montanara P et al: What we know and would like to know about CDKL5 and its involvement in epileptic encephalopathy. Neural Plast 2012; 2012: 1-12.
14. Van Esch H, Jansen A, Bauters M et al: Encephalopathy and bilateral cataract in a boy with an interstitial deletion of Xp22 comprising the CDKL5 and NHS genes. Am J Med Genet A 2007; 143: 364-369.
15. Erez A, Patel AJ, Wang X et al: Alu-specific microhomology-mediated deletions in CDKL5 in females with early-onset seizure disorder. Neurogenetics 2009; 10: 363-369.
16. Bartnik M, Derwinska K, Gos M et al: Early-onset seizures due to mosaic exonic deletions of CDKL5 in a male and two females. Genet Med 2011; 13: 447-452.
17. Bahi-Buisson N, Girard B, Gautier A et al: Epileptic encephalopathy in a girl with an interstitial deletion of Xp22 comprising promoter and exon 1 of the CDKL5 gene. Am J Med Genet B Neuropsychiatr Genet 2009; 153B: 202-207.
18. Mei D, Marini C, Novara F et al: Xp22.3 genomic deletions involving the CDKL5 gene in girls with early onset epileptic encephalopathy. Epilepsia 2010; 51: 647-654.
19. Mari F, Azimonti S, Bertani I et al: CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet 2005; 14: 1935-1946.
20. Lin C, Franco B, Rosner MR: CDKL5/Stk9 kinase inactivation is associated with neuronal developmental disorders. Hum Mol Genet 2005; 14: 3775-3786.
21. Bertani I, Rusconi L, Bolognese F et al: Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation. J Biol Chem 2006; 281: 32048-32056.
22. Carouge D, Host L, Aunis D et al: CDKL5 is a brain MeCP2 target gene regulated by DNA methylation. Neurobiol Dis 2010; 38: 414-424.
23. Williamson SL, Giudici L, Kilstrup-Nielsen C et al: A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain. Hum Genet 2012; 131: 187-200.
24. Livide G, Patriarchi T, Amenduni M et al: GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. Eur J Hum Genet 2014; doi: 10.1038/ejhg.2014.81. (epub ahead of print).
25. Van Esch H, Bauters M, Ignatius J et al: Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 2005; 77: 442-453.
26. Ramocki MB, Peters SU, Tavyev YJ et al: Autism and other neuropsychiatric symptoms are prevalent in individuals with MECP2 duplication syndrome. Ann Neurol 2009; 66: 771-782.
27. Yeung A, Bruno D, Scheffer IE et al: 4.45 Mb microduplication in chromosome band 14q12 including FOXG1 in a girl with refractory epilepsy and intellectual impairment. Eur J Med Genet 2009; 52: 440-442.
28. Brunetti-Pierri N, Paciorkowski AR, Ciccone R et al: Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment. Eur J Hum Genet 2011; 19: 102-107.
29. Striano P, Paravidino R, Sicca F et al: West syndrome associated with 14q12 duplications harboring FOXG1. Neurology 2011; 76: 1600-1602.
30. Tohyama J, Yamamoto T, Hosoki K et al: West syndrome associated with mosaic duplication of FOXG1 in a patient with maternal uniparental disomy of chromosome 14. Am J Med Genet 2011; 155: 2584-2588.
31. Froyen G, Van Esch H, Bauters M et al. Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes. Hum Mutat 2007; 28: 1034-1042.
32. Tzschach A, Chen W, Erdogan F et al. Characterization of interstitial Xp duplications in two families by tiling path array CGH. Am J Med Genet A 2008; 146A: 197-203.
33. Thorson L, Bryke C, Rice G et al. Clinical and molecular characterization of overlapping interstitial Xp21-p22 duplications in two unrelated individuals. Am J Med Genet A 2010; 152A: 904-915.
34. Sismani C, Anastasiadou V, Kousoulidou L et al. 9 Mb familial duplication in chromosome band Xp22.2-22.13 associated with mental retardation, hypotonia and developmental delay, scoliosis, cardiovascular problems and mild dysmorphic facial features. Eur J Med Genet 2011; 54: e510-e515.
35. Boone PM, Bacino CA, Shaw CA et al: Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat 2010; 31: 1326-1342.
36. Wiszniewska J, Bi W, Shaw C et al: Combined array CGH plus SNP genome analyses in a single assay for optimized clinical testing. Eur J Hum Genet 2014; 22: 79-87.
37. Allen RC, Zoghbi HY, Moseley AB et al: Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51: 1229-1239.
38. Hastings PJ, Ira G, Lupski JR: A microhomology-mediated break-induced replication model for the origin of human copy number variation. PLoS Genet 2009; 5: e1000327.
39. Bahi-Buisson N, Nectoux J, Rosas-Vargas H et al: Key clinical features to identify girls with CDKL5 mutations. Brain 2008; 131: 2647-2661.
40. Nemos C, Lambert L, Giuliano F et al: Mutational spectrum of CDKL5 in early-onset encephalopathies: a study of a large collection of French patients and review of the literature. Clin Genet 2009; 76: 357-371.
41. Bahi-Buisson N, Bienvenu T: CDKL5-related disorders: from clinical description to molecular genetics. Mol Syndromol 2011; 2: 137-152.
42. Elia M, Falco M, Ferri R et al: CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy. Neurology 2008; 71: 997-999.
43. Liang JS, Shimojima K, Takayama R et al: CDKL5 alterations lead to early epileptic encephalopathy in both genders. Epilepsia 2011; 52: 1835-1842.
44. Mirzaa GM, Paciorkowski AR, Marsh ED et al: CDKL5 and ARX mutations in males with early-onset epilepsy. Pediatr Neurol 2013; 48: 367-377.
45. Sartori S, Di Rosa G, Polli R et al: A novel CDKL5 mutation in a 47, XXY boy with the early-onset seizure variant of Rett syndrome. Am J Med Genet A 2009; 149A: 232-236.
46. Kalscheuer VM, Tao J, Donnelly A et al: Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation. Am J Hum Genet 2003; 72: 1401-1411.
47. Montini E, Andolfi G, Caruso A et al: Identification and characterization of a novel serine-threonine kinase gene from the Xp22 region. Genomics 1998; 51: 427-433.
48. Scala E, Ariani F, Mari F et al: CDKL5/STK9 is mutated in Rett syndrome variant with infantile spasms. J Med Genet 2005; 42: 103-107.
49. Seltzer LE, Paciorkowski AR: Genetic disorders associated with postnatal microcephaly. Am J Med Genet C Semin Med Genet 2014; 166C: 140-155.
50. Brunetti-Pierri N, Berg JS, Scaglia F et al: Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet 2008; 40: 1466-1471.
51. Shinawi M, Liu P, Kang SH et al: Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010; 47: 332-341.
52. Crespi B, Stead P, Elliot M: Comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA 2010; 107(Suppl 1): 1736-1741.
53. Bahi-Buisson N, Kaminska A, Boddaert N et al: The three stages of epilepsy in patients with CDKL5 mutations. Epilepsia 2008; 49: 1027-1037.